Holly M. Horton

Person

Pasadena, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for treating IgE-mediated disorders
- Patent number 11,566,080
- Issue date Jan 31, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating IgE-mediated disorders
- Patent number 9,617,348
- Issue date Apr 11, 2017
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating IgE-mediated disorders
- Patent number 9,540,451
- Issue date Jan 10, 2017
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating IgE-mediated disorders
- Patent number 9,266,966
- Issue date Feb 23, 2016
- Xencor, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating IgE-mediated disorders
- Patent number 9,221,916
- Issue date Dec 29, 2015
- Xencor, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating IgE-mediated disorders
- Patent number 9,062,117
- Issue date Jun 23, 2015
- Xencor, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating IgE-mediated disorders
- Patent number 8,435,517
- Issue date May 7, 2013
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS
- Publication number 20230272114
- Publication date Aug 31, 2023
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions
- Publication number 20210205426
- Publication date Jul 8, 2021
- Xencor, Inc.
- John Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS
- Publication number 20200332024
- Publication date Oct 22, 2020
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS
- Publication number 20170335013
- Publication date Nov 23, 2017
- Xencor, Inc.
- JOHN R. DESJARLAIS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS
- Publication number 20150139985
- Publication date May 21, 2015
- Xencor, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS
- Publication number 20150093379
- Publication date Apr 2, 2015
- Xencor, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS
- Publication number 20130203967
- Publication date Aug 8, 2013
- Xencor, Inc.
- JOHN R. DESJARLAIS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS
- Publication number 20130203966
- Publication date Aug 8, 2013
- Xencor, Inc.
- JOHN R. DESJARLAIS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Compositions and Methods for Treating IgE-Mediated Disorders
- Publication number 20130177553
- Publication date Jul 11, 2013
- Xencor, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions
- Publication number 20110189178
- Publication date Aug 4, 2011
- Xencor, Inc.
- John Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS
- Publication number 20100080814
- Publication date Apr 1, 2010
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY

Holly M. Horton

Person

Patents Grantslast 30 patents

Compositions and methods for treating IgE-mediated disorders

Compositions and methods for treating IgE-mediated disorders

Compositions and methods for treating IgE-mediated disorders

Compositions and methods for treating IgE-mediated disorders

Compositions and methods for treating IgE-mediated disorders

Compositions and methods for treating IgE-mediated disorders

Compositions and methods for treating IgE-mediated disorders

Patents Applicationslast 30 patents

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS

Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS

Novel Compositions and Methods for Treating IgE-Mediated Disorders

Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS